Monday, July 27, 2026

▸▸ Revolutionizing Glioma Diagnosis with AI-Driven Precision | Sarvesh Amatya at Neuro Care 2026

Artificial intelligence and machine learning are transforming the future of brain tumor diagnosis by enabling faster, more accurate, and data-driven clinical decisions. Join the 2nd Edition of International Conference on Neurology and Neuroscience (Neuro Care-2027), taking place March 22–24, 2027 in Singapore and Online, and explore how intelligent technologies are advancing neuro-oncology.

🧬 Scientific Spotlight
"Precision Glioma Grading Using Voting-Based Feature Selection and Ensemble Machine Learning with Clinical and Molecular Data"

πŸŽ™️ Featured Researcher

Sarvesh Amatya
Alexander Dreyfoos School of the Arts, United States

▶️ Presentation Preview

https://www.youtube.com/watch?v=7iozc-uaeiE

πŸ’‘ Key Takeaways

◆ AI-assisted grading of gliomas using clinical and molecular data
◆ Feature selection methods for improving diagnostic accuracy
◆ Ensemble machine learning models in neuro-oncology
◆ Supporting precision medicine for brain tumor management
◆ Reducing complexity while maintaining predictive performance
◆ Improving decision-making through data-driven analysis
◆ Future applications of AI in neurological diagnostics

🌐 Conference Portal
https://neurocareconference.com/

πŸ“‘ Abstract Submission
https://neurocareconference.com/abstract-submission

πŸŽ₯ Scientific Videos & Conference Updates
https://www.youtube.com/@MathewsInternationalLLC

Join neurologists, oncologists, AI researchers, clinicians, and healthcare innovators as they explore how machine learning is reshaping brain tumor diagnosis and driving the future of precision neurological care.

#NeuroCare2027 #Glioma #ArtificialIntelligence #MachineLearning #BrainTumor #NeuroOncology #PrecisionMedicine #Neuroscience #ClinicalResearch #HealthcareInnovation #Singapore2027 #NeurologyConference


No comments:

Post a Comment